Informations sur le produit
- disodium (4R,5R,6S)-3-[(3S,5S)-5-[(3-carboxylatophenyl)carbamoyl]pyrro lidin-3-yl]sulfanyl-6-(1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
- 1-Azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 3-(((3S,5S)-5-(((3-ca rboxyphenyl)amino)carbonyl)-3-pyrrolidinyl)thio)-6-((1R)-1-hydroxyethy l)-4-methyl-7-oxo-, monosodium salt, (4R,5S,6S)-
- disodium (4R,5S,6S)-3-({(3S,5S)-5-[(3-carboxylatophenyl)carbamoyl]pyrrolidin-3-yl}sulfanyl)-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
- disodium (4R,5R,6S)-3-[(3S,5S)-5-[(3-carboxylatophenyl)carbamoyl]pyrrolidin-3-yl]sulfanyl-6-(1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
Ertapenem disodium is a salt form of ertapenem, which is an antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins. It has been shown to have antibacterial efficacy against a number of gram-positive species, including Streptococcus pneumoniae and Enterococcus faecalis. Ertapenem disodium exhibits concentration-dependent bactericidal activity against Escherichia coli and Staphylococcus aureus. Ertapenem disodium has been shown to be effective in the treatment of patients with mild-to-moderate infections caused by Escherichia coli or Staphylococcus aureus. This drug should not be used in patients who are hypersensitive to ertapenem or other beta-lactam antibiotics because it can cause allergic reactions, severe diarrhea, and seizures.
